GE HealthCare Technologies Inc. $GEHC Shares Sold by Bradley Foster & Sargent Inc. CT

Bradley Foster & Sargent Inc. CT trimmed its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 22.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 104,065 shares of the company’s stock after selling 30,582 shares during the quarter. Bradley Foster & Sargent Inc. CT’s holdings in GE HealthCare Technologies were worth $7,815,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Colonial Trust Advisors increased its holdings in GE HealthCare Technologies by 11.1% in the 3rd quarter. Colonial Trust Advisors now owns 1,391 shares of the company’s stock worth $104,000 after buying an additional 139 shares during the period. Tableaux LLC purchased a new stake in shares of GE HealthCare Technologies in the 3rd quarter valued at $301,000. TD Asset Management Inc increased its stake in shares of GE HealthCare Technologies by 4.0% in the third quarter. TD Asset Management Inc now owns 377,043 shares of the company’s stock worth $28,316,000 after acquiring an additional 14,675 shares during the period. Mufg Securities Americas Inc. raised its holdings in shares of GE HealthCare Technologies by 21.3% during the third quarter. Mufg Securities Americas Inc. now owns 12,312 shares of the company’s stock worth $925,000 after purchasing an additional 2,164 shares during the last quarter. Finally, Compound Planning Inc. acquired a new position in GE HealthCare Technologies during the third quarter valued at $202,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have weighed in on GEHC. Jefferies Financial Group lifted their price objective on GE HealthCare Technologies from $95.00 to $105.00 and gave the company a “buy” rating in a research note on Thursday, December 11th. Bank of America lifted their price target on GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a research report on Monday, January 5th. Barclays upped their price objective on GE HealthCare Technologies from $86.00 to $87.00 and gave the stock an “equal weight” rating in a research report on Friday, February 6th. Morgan Stanley increased their target price on shares of GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research note on Wednesday, February 4th. Finally, The Goldman Sachs Group reissued a “buy” rating and issued a $98.00 price target on shares of GE HealthCare Technologies in a research note on Friday, January 9th. Seven analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $92.50.

GE HealthCare Technologies Stock Down 0.0%

Shares of NASDAQ GEHC opened at $84.03 on Thursday. GE HealthCare Technologies Inc. has a 1 year low of $57.65 and a 1 year high of $92.20. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.37 and a quick ratio of 1.13. The company has a market capitalization of $38.30 billion, a P/E ratio of 18.43, a P/E/G ratio of 1.85 and a beta of 1.08. The company has a 50 day simple moving average of $82.33 and a 200-day simple moving average of $78.29.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, beating the consensus estimate of $1.40 by $0.04. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The business had revenue of $5.70 billion for the quarter, compared to analyst estimates of $5.60 billion. During the same quarter in the prior year, the company posted $1.45 EPS. The company’s quarterly revenue was up 7.1% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. On average, equities research analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be paid a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Thursday, April 2nd. GE HealthCare Technologies’s payout ratio is 3.07%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.